Clinical Trials · NCT04081337
A Study to Measure Energy Expenditure and Food Intake in Participants With Obesity Using Tirzepatide
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 55
- Start date
- Jul 2020
- Locations
- 1 site, United States
- Primary endpoint
- Change From Baseline to Week 18 in Sleep Metabolic Rate (SMR)